Cargando…
Effect of botulinum toxin type A on non-motor symptoms and quality of life in Meige syndrome
BACKGROUND: It has been shown in previous studies that botulinum toxin type A (BTX-A) can effectively relieve the motor symptoms of Meige syndrome. However, its effect on non-motor symptoms (NMS) and quality of life (QoL) has not been comprehensively studied. This study aimed to explore the effects...
Autores principales: | Zheng, Heqing, Wu, Lanxiang, Tian, Sheng, Liu, Mingxu, Zhan, Qingqing, Yu, Xinping, Xie, Yonggang, Zhong, Xianhui, Wu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947842/ https://www.ncbi.nlm.nih.gov/pubmed/36846150 http://dx.doi.org/10.3389/fneur.2023.1115482 |
Ejemplares similares
-
Dietary niacin intake in relation to depression among adults: a population-based study
por: Tian, Sheng, et al.
Publicado: (2023) -
Identification of autophagy-related genes in neuropathic pain through bioinformatic analysis
por: Tian, Sheng, et al.
Publicado: (2023) -
Botulinum toxin type A promotes microglial M2 polarization and suppresses chronic constriction injury-induced neuropathic pain through the P2X7 receptor
por: Gui, Xianwei, et al.
Publicado: (2020) -
Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23
por: Wang, Xuan, et al.
Publicado: (2020) -
Efficacy and safety of botulinum toxin for treating motor dysfunction in patients with Parkinson’s disease: a systematic review and meta-analysis
por: Yang, Yuqi, et al.
Publicado: (2023)